tiprankstipranks
Trending News
More News >

CareRx Q2 2024: Revenue Up, Adjusted EBITDA Grows

Story Highlights
CareRx Q2 2024: Revenue Up, Adjusted EBITDA Grows

CareRx (TSE:CRRX) has released an update.

Confident Investing Starts Here:

CareRx Corporation reported a mixed financial performance for Q2 2024 with a revenue of $92.0 million and an increased adjusted EBITDA of $7.5 million, despite facing a net loss of $1.4 million. The company remains committed to improving productivity and managing costs, while capitalizing on growth opportunities in the seniors living sector.

For further insights into TSE:CRRX stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1